Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
specificThe reemergence of primary mediastinal large B-cell lymphoma after a period of remission.
11
Centers
14
Active Trials
—
Cancer Funding
Top Centers for Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center | 70.9 |
| 2 | University of Illinois Cancer CenterChicago, IL High-Volume Research Center | 70.9 |
| 3 | Cancer Center at IllinoisUrbana, IL High-Volume Research Center | 70.9 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 48.4 |
| 5 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 48.4 |
| 6 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 48.4 |
| 7 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 48.4 |
| 8 | Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive Active Research Program | 48.4 |
| 9 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 48.4 |
| 10 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 48.4 |
| 11 | Upstate Cancer CenterSyracuse, NY Active Research Program | 48.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →